A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
A Comparative Study of Efficacy and Tolerability of Dorzolamide and Timolol Maleate in Pre-Operative Cataract Patients
2012
Journal of Pharmaceutical Research
The drugs currently available for treatment of glaucoma are â-blockers, sympathomimetics, carbonic anhydrase inhibitors (CAIs) and prostaglandin analogues 1 . Apart from their use in glaucoma to reduce IOP, the antiglaucoma drugs are also used routinely for pre-operative reduction of IOP even in nonglaucomatous patients subjected for intraocular surgery to prevent expulsive haemorrhage and bulging of anterior segment. Objectives: To assess the safety and tolerability of 2% dorzolamide and 0.5%
doi:10.18579/jpcrkc/2012/11/1/79332
fatcat:xdu5p6p4qnerpcirmqemeplfxu